MICA II Study Group

Vancheswaran Gopalakrishnan: Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Christopher Morehouse: Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Jerome Bouquet: Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Bret Sellman: Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Paul Warrener: Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Carolina Caceres: Translational Scientific Management, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA; Ventzislava A. Hristova: Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Sonja Hess: Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Raghothama Chaerkady: Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Matthew S. Glover: Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Steven Novick: Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Junmin Wang: Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Bairu Zhang: Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Tianhui Zhang: Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Natalie van Zuydam: Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Bastian Angerman: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Christopher McCrae: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Daniel Muthas: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Michael Hühn: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Lisa Öberg: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Hanna Duàn: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Glenda Lassi: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Gary Sims: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Kristoffer Ostridge: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden and Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Alex Mackay: Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden and NHLI, Imperial College, London, UK; Adam Platt: VP and Head of Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Antonio DiGiandomenico: Microbial Antibodies and Technologies, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Jodie Ackland: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Ashley I. Heinson: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; D. Cellura: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Anthony D. Postle: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; C. Mirella Spalluto: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Kerry Day: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Alex Hicks: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Nicholas P. Williams: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK; Karl J. Staples: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK and NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Tom M.A Wilkinson: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK and NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK (nominated consortia representative); Hannah Burke: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK and NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Anna Freeman: Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK and NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Maria G. Belvisi: SVP and Head of Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Sarah Bawden: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Esther Nyimbili: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Laura Presland: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Nicola Rayner: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Pedro Rodrigues: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Andria Staniford: NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Alastair Watson: Faculty of Medicine, University of Southampton, Southampton, and School of Clinical Medicine, University of Cambridge, Cambridge, UK; Graham Belfield: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Stephanie Ashenden: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Damla Etal: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Aurelie Bornot: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Fredrik Karlsson: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Karl Nordström: Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Outi Vaarala: Faculty of Medicine, University of Helsinki, Helsinki, Finland; Chia-Chien Chiang: Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Shameer Khader: Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Wen Yu: Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Xiaotao Qu: Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Bruce Thompson: Swinburne University of Technology Melbourne, Australia; Ulrika Edvardsson: Business Development and Licensing, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Stephen Harden: University Hospital Southampton NHS Foundation Trust, Southampton, UK.